Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-02-22 @ 2:37 AM
Study NCT ID:
NCT03830918
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-14
First Post:
2019-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Malignant Solid Neoplasm | View |
| None | Extensive Stage Lung Small Cell Carcinoma | View |
| None | Stage III Lung Cancer AJCC v8 | View |
| None | Stage IIIA Lung Cancer AJCC v8 | View |
| None | Stage IIIB Lung Cancer AJCC v8 | View |
| None | Stage IIIC Lung Cancer AJCC v8 | View |
| None | Stage IV Lung Cancer AJCC v8 | View |
| None | Stage IVA Lung Cancer AJCC v8 | View |
| None | Stage IVB Lung Cancer AJCC v8 | View |